Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.

The potential applications of artificial intelligence (AI) in biopharmaceuticals appear wide-ranging and transformative.

A new report from the United States Sentencing Commission analyzes convictions from 2019 to 2023, and the impact of mandatory ...

The investment of over $6 million will expand LGM Pharma’s Rosenberg, Texas manufacturing facility as part of its Phase I ...

The Federal Trade Commission and Department of Health and Human Services are examining the practices of group purchasing organizations and drug wholesalers and the role they may play in triggering ...

If you’ve ever called an ambulance to your house, you know they keep a kit full of medications and anything they need with them so they’re ready to respond to any ...

President Donald Trump‘s executive crusade to punish three countries he deems responsible for the deadly fentanyl epidemic has raised questions on whether tariffs, especially on Canada, will solve the ...

WILMINGTON, Del. & WHIPPANY, N.J.--(BUSINESS WIRE)--The Noramco Group, an integrated North American-based API and drug product supply chain product and services provider, today announced a $25 million ...

Learn how hospitals are cutting costs by buying directly from pharmaceutical companies, as drug prices continue to rise and impact operating losses.

In 2024, the Food and Drug Administration (FDA) significantly invested in reorganizing its internal infrastructure and enhancing operations.

The legislation headed to Gov. Glenn Youngkin’s desk would establish a Prescription Drug Affordability Board. The board would ...